# A Study of Definitive Therapy to Treat Prostate Cancer

> **NCT02716974** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 26 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Leuprolide Acetate
- **DRUG:** Bicalutamide
- **DRUG:** Docetaxel
- **PROCEDURE:** Prostatectomy
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT02716974
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716974, "A Study of Definitive Therapy to Treat Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02716974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*